EASD 2023

Weekly insulin icodec is noninferior to once-daily insulin degludec in people with type 1 diabetes, indicate findings from the ONWARDS 6 trial.

SURMOUNT-3 results indicate tirzepatide can enhance the weight loss achieved following an intensive lifestyle intervention.

The insulin analog faster aspart is a viable alternative to insulin aspart as a treatment for pregnant and breastfeeding women with type 1 and type 2 diabetes.

The SURPASS-6 findings support the addition of tirzepatide to basal insulin for people with poorly controlled type 2 diabetes, demonstrating significant improvements in mean glycated hemoglobin and other benefits compared with use of adjunct insulin lispro.

Diabetes increases the risk of development of depressive symptoms, with this study finding a significant linear relationship between diabetes severity and risk of depression.

A new phase 2 study shows that the insulin-producing function of beta cells is preserved for longer periods of time in people with newly diagnosed type 1 diabetes who are treated with antivirals pleconaril and ribavirin.

Real-world data from 23,442 patients taking weekly semaglutide injections shows improvement in weight and HbA_1c levels over a 3-year period, with more pronounced results in patients with greater adherence to treatment.

Low muscle mass increases risk of all-cause mortality in people with diabetes, with double the risk for cardiovascular-disease-related deaths compared to those with normal muscle mass.

Women who have experienced gestational diabetes have a higher risk of developing chronic kidney disease, with an increased risk of 92% compared to women without GDM.

Both SGLT2 inhibitors and GLP-1 receptor agonists have been shown to lower the risk of microvascular complications over a 5-year period in people with type 2 diabetes, according to a large retrospective cohort analysis.

In the past 15 years, mortality rates after a first heart attack have dropped significantly for people with type 2 diabetes but this is not the case for people with type 1 diabetes.

Adolescents and young adults with type 2 diabetes have a higher risk of myocardial infarction and heart failure compared to their peers with type 1 diabetes.

New evidence-based European guidelines provide strengthened and expanded recommendations on dietary management of type 2 diabetes, including dietary patterns, environmental sustainability, food processing, and patient support.

The presence of diabetes mellitus (DM) represents a significant risk factor for the development of heart failure (HF). Individuals with DM are approximately 2–5 times more likely to develop heart failure at a younger age [ 1 ]. Clinical studies …

During the last decades, cardiovascular disease (CVD) risk is increased in obese patients with diabetes mellitus (DM) [ 1 ]. However, nowadays, there is an increasing prevalence of type 2 DM (T2DM) with lean/normal body mass index (BMI), which was …

People living with diabetes have many medical devices available to assist with disease management. A critical aspect that must be considered is how systems for continuous glucose monitoring and insulin pumps communicate with each other and how the …